sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive...

6
Br HeartJ 1993;70:135-140 Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates Mauro Pepi, Gian Carlo Marenzi, Pier Giuseppe Agostoni, Elisabetta Doria, Paolo Barbier, Manuela Muratori, Fabrizio Celeste, Maurizio D Guazzi Istituto di Cardiologia delil' Universiti degli Studi, Istituto di Ricerche Cardiovascolari "G Sisini", Fondazione "I Monzino" IRCCS, Centro di Ricerche Cardiovascolari del C N R, Milan, Italy M Pepi G C Marenzi P G Agostoni E Doria P Barbier M Muratori F Celeste M D Guazzi Correspondence to: Dr M Pepi, Istituto di Cardiologia, Via Bonfadini 214, 20138 Milan, Italy. Accepted for publication 18 February 1993 Abstract Objective-To investigate the pathophys- iological (cardiac fimction and physical performance) significance of clinically silent interstitial lung water accumula- tion in patients with moderate heart fail- ure; to use isolated ultrafiltration as a means of extravascular fluid reabsorp- tion. Design-Echocardiographic, Doppler, chest x-ray evaluations, and cardiopul- monary tests at baseline, soon after ultrafiltration (veno venous extracorpo- real circuit), and four days, one month, and three months later. Setting-University institute of cardio- logy. Subjects-24 patients with heart failure due to idiopathic dilated cardiomyopathy or ischaemic myocardial disease with sinus rhythm and ejection fraction less than 35%. Twelve were randomised to ultrafiltration and 12 were taken as controls. Main outcome measures-Left ventricu- lar systolic function (from ultrasonogra- phy); Doppler evaluation of mitral, tricuspid, and aortic flow and echo- Doppler determination of cardiac out- put; radiological score of extravascular lung water; right and left ventricular fill- ing pressures; oxygen consumption at peak exercise and exercise tolerance time in cardiopulmonary tests. Results-Soon after ultrafiltration (1976 (760) ml of fluid removed) the following was observed: a reduction in radiological score of extravascular lung water (from 15(1) to 9(1)) and of right (from 7*1 (2.3) to 2-3 (1.7) mm Hg) and left (from 17*6 (8-8) to 9-S (6.4) mm Hg) ventricular fill- ing pressures; an increase in oxygen con- sumption at peak exercise (from 15-8 (3.3) to 17-6 (2) mllminlkg) and of toler- ance time (from 444 (138) to 508 (134) s); a slight decrease in atrial and ventricular dimensions; no changes in the systolic fimction of the left ventricle; a reduction of the early to late filling ratio in both ventricles (mitral valve from 2 (2) to 1.1 (1-1)); (tricuspid valve from 1-3 (1.3) to 0-69 (0-18)) and an increase in the decel- eration time of mitral and tricuspid flow, reflecting a redistribution of filling to late diastole. Variations in the ventricu- lar filling pattern, lung water content, and functional performance persisted for three months in all cases. None of these changes was detected in the control group. Conclusions-Reduction of interstitial lung water was probably the mechanism whereby ultrafiltration modified the pat- tern of filling of the two ventricles and improved fimctional performance. (Br HeartJ_ 1993;70:135-140) Patients who have moderate cardiac insuffi- ciency while taking maintenance doses of frusemide and whose water balance is appar- ently in equilibrium, may have radiological signs of congestion and fluid accumulation in the interstitial space of the lungs.' The patho- physiological meaning of this clinically silent pulmonary overhydration is unknown. Its removal may help to define its importance. A simple method to clear the lungs might be the administration of supplemental doses of frusemide2 or vasodilators3 to lower the hydrostatic forces (left atrial pressure) that facilitate an excessive filtration of fluid. These categories of drugs, however, may cause humoral effects (stimulation of renin secre- tion, rise in circulating noradrenaline concen- tration, electrolyte imbalance)4 or vascular effects (systemic vasodilatation, blood venous pooling),78 or both, which make it hard to discern how much of the observed changes is attributable to clearing of the lungs and how much to other effects. Ultrafiltration effectively promotes reab- sorption of extravascular water and resolves pulmonary oedema in patients with cardiac failure, overhydration, and refractoriness of the disease to pharmacological remedies.>" We assumed that ultrafiltration, as a physical method, is more suitable than pharmacologi- cal methods to investigate the effects of removal of fluid accumulation in the intersti- tial space of the lung. It is not too invasive a technique (cannulation of the femoral vein) and has few complications." "'34 We evalu- ated the cardiac effects of a single filtration with echo-Doppler techniques and by assess- ing changes in physical performance from the results of cardiopulmonary stress tests. Patients were followed up for three months. 135 on February 23, 2020 by guest. Protected by copyright. http://heart.bmj.com/ Br Heart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. Downloaded from

Upload: others

Post on 14-Feb-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Br HeartJ 1993;70:135-140

Sustained cardiac diastolic changes elicited byultrafiltration in patients with moderatecongestive heart failure: pathophysiologicalcorrelates

Mauro Pepi, Gian Carlo Marenzi, Pier Giuseppe Agostoni, Elisabetta Doria,Paolo Barbier, Manuela Muratori, Fabrizio Celeste, Maurizio D Guazzi

Istituto di Cardiologiadelil' Universitidegli Studi, Istitutodi RicercheCardiovascolari"G Sisini",Fondazione"I Monzino" IRCCS,Centro di RicercheCardiovascolari delC N R, Milan, ItalyM PepiG C MarenziP G AgostoniE DoriaP BarbierM MuratoriF CelesteM D GuazziCorrespondence to:Dr M Pepi, Istituto diCardiologia, Via Bonfadini214, 20138 Milan, Italy.Accepted for publication18 February 1993

AbstractObjective-To investigate the pathophys-iological (cardiac fimction and physicalperformance) significance of clinicallysilent interstitial lung water accumula-tion in patients with moderate heart fail-ure; to use isolated ultrafiltration as ameans of extravascular fluid reabsorp-tion.Design-Echocardiographic, Doppler,chest x-ray evaluations, and cardiopul-monary tests at baseline, soon afterultrafiltration (veno venous extracorpo-real circuit), and four days, one month,and three months later.Setting-University institute of cardio-logy.Subjects-24 patients with heart failuredue to idiopathic dilated cardiomyopathyor ischaemic myocardial disease withsinus rhythm and ejection fraction lessthan 35%. Twelve were randomised toultrafiltration and 12 were taken ascontrols.Main outcome measures-Left ventricu-lar systolic function (from ultrasonogra-phy); Doppler evaluation of mitral,tricuspid, and aortic flow and echo-Doppler determination of cardiac out-put; radiological score of extravascularlung water; right and left ventricular fill-ing pressures; oxygen consumption atpeak exercise and exercise tolerance timein cardiopulmonary tests.Results-Soon after ultrafiltration (1976(760) ml of fluid removed) the followingwas observed: a reduction in radiologicalscore of extravascular lung water (from15(1) to 9(1)) and of right (from 7*1 (2.3)to 2-3 (1.7) mm Hg) and left (from 17*6(8-8) to 9-S (6.4) mm Hg) ventricular fill-ing pressures; an increase in oxygen con-sumption at peak exercise (from 15-8(3.3) to 17-6 (2) mllminlkg) and of toler-ance time (from 444 (138) to 508 (134) s);a slight decrease in atrial and ventriculardimensions; no changes in the systolicfimction of the left ventricle; a reductionof the early to late filling ratio in bothventricles (mitral valve from 2 (2) to 1.1(1-1)); (tricuspid valve from 1-3 (1.3) to0-69 (0-18)) and an increase in the decel-eration time of mitral and tricuspid flow,reflecting a redistribution of filling to

late diastole. Variations in the ventricu-lar filling pattern, lung water content,and functional performance persisted forthree months in all cases. None of thesechanges was detected in the controlgroup.Conclusions-Reduction of interstitiallung water was probably the mechanismwhereby ultrafiltration modified the pat-tern of filling of the two ventricles andimproved fimctional performance.

(Br HeartJ_ 1993;70:135-140)

Patients who have moderate cardiac insuffi-ciency while taking maintenance doses offrusemide and whose water balance is appar-ently in equilibrium, may have radiologicalsigns of congestion and fluid accumulation inthe interstitial space of the lungs.' The patho-physiological meaning of this clinically silentpulmonary overhydration is unknown. Itsremoval may help to define its importance. Asimple method to clear the lungs might be theadministration of supplemental doses offrusemide2 or vasodilators3 to lower thehydrostatic forces (left atrial pressure) thatfacilitate an excessive filtration of fluid. Thesecategories of drugs, however, may causehumoral effects (stimulation of renin secre-tion, rise in circulating noradrenaline concen-tration, electrolyte imbalance)4 or vasculareffects (systemic vasodilatation, blood venouspooling),78 or both, which make it hard todiscern how much of the observed changes isattributable to clearing of the lungs and howmuch to other effects.

Ultrafiltration effectively promotes reab-sorption of extravascular water and resolvespulmonary oedema in patients with cardiacfailure, overhydration, and refractoriness ofthe disease to pharmacological remedies.>"We assumed that ultrafiltration, as a physicalmethod, is more suitable than pharmacologi-cal methods to investigate the effects ofremoval of fluid accumulation in the intersti-tial space of the lung. It is not too invasive atechnique (cannulation of the femoral vein)and has few complications." "'34 We evalu-ated the cardiac effects of a single filtrationwith echo-Doppler techniques and by assess-ing changes in physical performance from theresults of cardiopulmonary stress tests.Patients were followed up for three months.

135

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from

Page 2: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Pepi, Marenzi, Agostoni, Doria, Barbier, Muratoi, Celeste, Guazzi

Patients and methodsPATIENTSTwenty four consecutive patients wererecruited to the study and satisfied the follow-ing selection criteria: (a) they had clinicallysilent but radiologically evident increasedinterstitial lung water without pleural, peri-cardial, or abdominal effusion; (b) they hadregular sinus rhythm in an electrocardiogram;(c) they had good quality ultrasound andDoppler recordings; (d) they had no severe(>3 +) mitral or tricuspid regurgitation"5; and(e) they gave written consent to the studyafter receiving detailed information about theprocedures, the possible clinical benefits, andthe investigative purposes. These patientswere screened from 61 patients with conges-tive heart failure. Twelve of them (11 menand 1 woman, whose age ranged between 52and 69 (mean 57)) were randomised toreceive ultrafiltration; the other 12 were notsubjected to ultrafiltration and were followedup for the same period with the same meth-ods. The protocol was approved by the ethi-cal committee of the Institute of Cardiology,University of Milan.

All subjects had primary or secondarymyocardial disease (table 1); their peak oxy-gen uptake obtained during exercise (peakVo2) ranged beween 11-7 and 24-4 ml/min/kg.Based on maximal peak Vo2 classification16two patients were in functional class A, 13 inclass B, and nine in class C; the echocardio-graphically determined left ventricular minoraxis at end diastole exceeded 6 cm (mean 7-4cm), left ventricular shortening fraction wasless than 25%, and left ventricular ejectionfraction was less than 35%. After admissioneach patient received his or her usual outpa-tient doses of digoxin (0-25 mg/day),frusemide (60 (20) mg/day), and captopril(eight in the treated group and eight in thecontrol group), and these were kept constantfor each patient throughout the study.

STUDY DESIGNPatients were admitted to the intensive careunit for the invasive procedures. Intravascularmeasurements were performed in all casesand were repeated immediately after a singleultrafiltration in the 12 patients subjected tothe procedure. Chest radiography, echocar-diographic and Doppler evaluations, and car-diolpulmonary exercise tests were performedthe day before ultrafiltration and four days,one month, and three months thereafter. Incontrol subjects these evaluations were car-ried out at the same intervals as in the treatedgroup.

ULTRAFILTRATIONThe procedure has been described previouslyin more detail." In brief, a D20SF Amicondiafilter (Danvers, Massachusetts), whichallows filtration of plasma water and solutesof less than 50 000 daltons, was inserted intoa veno venous extracorporeal circuit with adouble lumen Y shaped catheter percuta-neously introduced into a femoral vein. Theflow through the circuit was driven by a

Gambro system (Lund, Sweden) AK10 peri-staltic pump regulated to generate ultrafiltrateat a rate of 600 ml/h. The procedure was con-tinued until right atrial pressure was loweredto 50% of baseline values; this correspondedto a mean ultrafiltrate of 1926(760) ml.

HAEMODYNAMIC MEASUREMENTSFor the intravascular evaluations a flowdirected triple lumen thermodilution catheter(No 7F) was inserted percutaneously into asubclavian or jugular vein and advanced tothe pulmonary artery or, when necessary, tothe wedge position. The proximal port of thecatheter was used to measure pressure in theright atrium. Systemic arterial pressure wasderived from a polyethylene cathether inser-ted into the femoral artery. Pressures weredetermined with Hewlett-Packard straingauge transducers (model 128 6B) andrecorded on a Hewlett-Packard eight channelink recorder (model 1064 C). Cardiac outputwas obtained by thermodilution through anEdwards cardiac output computer (9520A);measurements were made in triplicate at eachperiod and the mean was taken as the repre-sentative value.

ECHOCARDIOGRAPHIC EXAMINATIONSEchocardiograms were recorded with aHewlett-Packard ultrasound unit, model77020A. Cross sectional views were used as aquality control check of the M mode calcula-tions. From the parastemal view the followingmeasurements were obtained: left atrial diam-tter, diastolic right ventricular dimension,diastolic (Dd) and systolic (Ds) left ventricu-lar cavity dimensions, and left ventricularfractional shortening, calculated as the per-centage of (Dd-Ds)/ Dd. The right atrialand right ventricular areas were measuredfrom the apical four chamber view; end dias-tolic and end systolic volumes of the left ven-tricle and left ventricular ejection fractionwere measured from the two chamber viewby the area-length method.

DOPPLER EVALUATIONSLeft and right ventricular diastolic filling wasevaluated through pulsed Doppler flow of themitral and tricuspid valve, respectively, with aHewlett-Packard ultrasound unit and a 2-5MHz transducer. Doppler recordings wereobtained from a four chamber view duringquiet regular respiration. The Doppler cursorline and sample volume were first placed inthe mitral funnel at an angle as parallel toflow as possible. The sample volume positionwas adjusted to record the maximal protodi-astolic velocity through the mitral valve. Thenthe cursor line was placed in the tricuspidfunnel to find the highest velocity of protodi-astolic flow. Doppler tracings were recordedat a paper speed of 50 mm/s and wereanalysed through a Kontron computer. Thefollowing variables were obtained: peakvelocity of early left and right ventricularfilling (PFVE), peak velocity of late leftand right ventricular filling (PFVA),PFVE/PFVA, and deceleration time (DT) of

136

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from

Page 3: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heartfailure: pathophysiological correlates

the mitral and tricuspid flow, which was

taken as the time required for the PFVE todecrease from its peak to baseline values. Allreported Doppler measurements were theaverages of 15 consecutive cardiac cycles.The degree of mitral and tricuspid regurgita-tion was measured by the method ofMiyatake et al: 1 + (mild), 2 + (moderate),3+ (moderate to severe), 4+ (severe).'5

Cardiac output was calculated non inva-sively according to the following formula'7:

Cardiac output = VTI x A x heart rate,

where VTI was the velocity time integral ofthe systolic velocity spectrum recorded in theoutflow tract of the left ventricle (five cham-ber view) and A was the subvalvar area of theleft ventricular outflow tract (M mode).

CARDIOPULMONARY EXERCISE TESTS ANDCHEST RADIOLOGYPhysical performance was evaluated throughcardiopulmonary exercise tests that were per-

formed while the patient was upright, on a

cycloergometer with 30 seconds of unloadedpedalling followed by 25 W increments every

three minutes until the patient developedlimiting dyspnoea or fatigue. All patients were

carefully instructed on how to perform car-

diopulmonary exercise. The investigatorsassisting patients during exercise tests wereblind to the patient's experimental condition.Oxygen consumption at peak exercise (peakV02) (ml/min/kg) was expressed as a meanover 30 seconds.

Extravascular lung water was graded byscoring pulmonary interstitial oedema in achest radiograph.'8

INTRAOBSERVER AND INTEROBSERVERVARIABILITY AND STATISTICAL METHODSThe results for each patient were analysed atthe end of the follow up in one session by

three independent experts who were blind tothe study protocol. The Doppler-echocardio-graphic examination was not repeated by a

different observer in the ultrasound labora-tory because of time constraints. To measure

interobserver variability all recorded datawere examined on two occasions, one monthapart, by two investigators. To assess intraob-server variability one investigator measuredthe same set of cardiac cycles on two occa-

sions (two weeks apart).For echocardiographic and Doppler data

intraobserver variability was 4% and 5% andinterobserver variability 5% and 6%, respec-

tively. For scoring of chest radiographsintraobserver variability was 8% and interob-server variability 9%. Differences between thetwo groups at each step of the study were

evaluated by a paired Student's t test. Linearregression was used to correlate echocardio-graphic, Doppler, and haemodynamic datawith each other.

ResultsFUNCTIONAL CAPACITYUltrafiltration removed an amount of fluidranging between 1220 and 2300 ml (mean1926 (760)) and did not cause complicationsor side effects. Two patients had slightreversible hypotension during the procedure.

Table 1 reports the individual peak Vo2,exercise tolerance time, and chest radiology atthe various steps of the study. In the twogroups of patients baseline peak Vo,, exercisetolerance time, and radiological score indexfor lung water content were similar. In thecontrol patients these variables did not showsignificant changes during the follow up. Inpatients receiving ultrafiltration, however,peak Vo, and exercise tolerance time were

significantly raised and the score for lungwater was reduced at four, 30, and 90 daysafter ultrafiltration.

Table 1 Clinical data and radiological score in study and control populations at baseline and duringfollow up

Peak VO, Exercise tolerance time Radiological score indexCase AgeNo (years) Diagnosis Baseline Day 4 Day 30 Day 90 Baseline Day 4 Day 30 Day 90 Baseline Day 4 Day 30 Day 90

Study population:1 63 Ischaemic heart disease 16 18 20-1 20-7 585 600 615 630 16 7 9 112 52 Ischaemicheartdisease 16-1 21 7 21-1 21 545 630 735 600 14 7 9 93 57 Primary cardiomyopathy 24-4 21-5 22-8 20-8 645 690 735 765 15 8 8 84 69 Primary cardiomyopathy 15-4 16 16-2 15-3 540 540 540 555 16 10 10 105 49 Primary cardiomyopathy 15 17-9 15 23-1 465 570 585 735 14 10 10 96 60 Primary cardiomyopathy 11-7 11-5 15-4 16 330 450 375 375 15 10 9 107 55 Primary cardiomyopathy 13-6 17-3 16-4 20 390 435 495 540 13 9 10 98 61 Ischaemic heart disease 15-5 18-8 20-1 23-2 420 510 450 480 16 10 11 119 59 Ischaemic heart disease 12-5 13-8 15-3 12-4 210 195 255 225 14 10 11 11

10 56 Primary cardiomyopathy 17-3 17-3 16 19-6 345 360 390 390 14 10 10 1011 55 Primary cardiomyopathy 18-4 19-6 20-9 22-7 585 570 585 660 12 10 10 1012 52 Primary cardiomyopathy 13-8 17-8 15-5 16 270 435 345 360 16 9 11 12

Means (SD) 57(5) 15-8 (3 3) 17-6 (2)* 17-9 (2)* 19-2 (3)* 444 (138) 498 (134)* 508 (151)* 526 (164)* 15 (1) 9 (1)*10 (1)* 10 (1)*

Control population:13 61 Ischaemic heart disease 15-4 15-8 15-9 16 540 560 530 520 16 16 16 1614 53 Primary cardiomyopathy 15-9 15-7 16 16 520 500 480 480 13 14 14 1415 58 Ischaemic heart disease 23 23-2 23-1 22 630 645 660 630 11 10 11 1116 65 Primary cardiomyopathy 16 15-9 14 15 480 475 465 420 11 11 10 1217 47 Primary cardiomyopathy 12 12-4 13 13 300 320 350 310 14 14 14 1418 63 Ischaemic heart disease 19-6 19-7 19-4 18-9 520 510 530 500 13 13 13 1319 54 Ischaemic heart disease 12-4 12-7 12-9 13 240 285 240 270 14 13 14 1420 58 Ischaemic heart disease 18-4 18-9 18-6 18-9 580 560 530 500 13 13 12 1421 53 Ischaemic heart disease 14 13-4 14-4 14 310 300 330 350 16 16 16 1622 58 Primary cardiomyopathy 14-4 14-6 12 13 430 470 420 430 14 15 16 1523 50 Primary cardiomyopathy 17-2 17 18-1 17 500 490 480 475 12 12 12 1224 60 Ischaemic heart disease 16-1 17-2 17 16 450 475 460 430 14 14 14 14

Mean (SD) 56(5) 16-2 (3) 16-3 (3) 16-2 (3) 16 (3) 458 (119) 465 (110) 456 (110) 442 (98) 13 (2) 13 (2) 13 (2) 14 (1)

*p < 0-02 Compared with corresponding control group value.

137

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from

Page 4: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Pepi, Marenzi, Agostoni, Doria, Barbier, Muratori, Celeste, Guazzi

Table 2 Haemodynamic data in study and control population. Values are means (SD)

Study population

Baseline After ultrafiltration Control population

Heart rate (beats/min) 74 (16) 76 (18) 78 (18)Mean aortic pressure (mm Hg) 88-3 (11-3) 85-3 (14-2) 86 (13-3)Mean pulmonary artery pressure (mm Hg) 26-4 (12-8) 17-5 (9.2)* 24-6 (13)Mean right atrial pressure (mm Hg) 7-1 (2-3) 3-1 (1-7)* 6-8 (2)Mean wedge pressure (mm Hg) 17-6 (8 8) 9 5 (6 4)* 16-8 (7)Cardiac index (1/min/m) 2-9 (0 58) 2-42 (0 66)* 2-7 (0 63)

*p < 0-01 Compared with baseline values.

HAEMODYNAMIC, ECHOCARDIOGRAPHIC, ANDDOPPLER DATAThe control and treated groups were homo-geneous in terms of heart rate, systemic andpulmonary artery pressures, filling pressuresof the two ventricles, and cardiac index (table2). The procedure did not produce significantchanges in heart rate and mean aortic pres-sure, but it significantly lowered right atrial,mean arterial, and wedge pulmonary pres-sures and the cardiac index. Left ventriculardiastolic and systolic diameters and volumes,right atrial and right ventricular areas, andleft atrial diameter were slightly decreasedimmediately after ultrafiltration and four dayslater; at subsequent evaluations no changesfrom baseline were detected (table 3). Thesystolic function of the left ventricle, as

measured by the fibre fractional shorteningand the ejection fraction, did not change dur-ing follow up. The cardiac index at echo-Doppler evaluation decreased immediatelyafter ultrafiltration and returned to baselinevalues at the one month follow up.

In the control group all these variableswere unchanged during the follow up.

As shown in table 4, ultrafiltration modi-fied the characteristics of left and right ven-

tricular filling. In fact, immediately afterultrafiltration peak velocities of early left andright ventricular filling were significantly low-ered and peak velocities of late ventricular fill-

ing of the two ventricles were raised. These

variations persisted in the next three months.

PFVE/PFVA of both atrioventricular valveswas significantly reduced and decelerationtime significantly augmented during the same

period. The figure shows representative trac-ings in a patient at the various stages of thestudy, with mean values of mitral and tri-cuspid PFVE/PFVA for the group at the samestages. Withdrawal of plasma water clearlyaffected the Doppler patterns and changeswere still quite evident after three months.During follow up ultrasound and Dopplervalues in the control group did not changesignificantly from baseline values.

Both before (24 patients) and after with-drawal of plasma water (12 patients) a posi-tive correlation was found between mitral andtricuspid PFVE/PFVA (before ultrafiltration:r = 0-68; p < 0-05; after ultrafiltration:r = 0-6; p < 0 05) and between mitral andtricuspid flow deceleration time (before ultra-filtration: r = 0 56; p < 0 05; after ultrafiltra-tion: r = 0-56; p < 0-05). Changes in PFVEof mitral flow with haemofiltration were rela-ted to changes in wedge pulmonary pressure(r = 0-78; p < 0.01), and variations in PFVEof tricuspid flow were related to those in rightatrial pressure (r = 0-68; p < 0-05).The cardiac index with the Doppler

technique significantly correlated with meas-

urements from thermodilution (before ultra-filtration: r = 0-92; SEE = 0-5; after ultra-filtration: r = 0 91; SEE = 06 I/min).

DiscussionPatients who underwent ultrafiltrationshowed improvement in exercise perfor-mance, reduction of the filling pressures ofthe two ventricles, and attenuation of theradiological signs of lung congestion. These

results persisted for three months in all cases.

The benefits of ultrafiltration in acute pul-monary oedema'4 and in severe congestiveheart failure912 have been interpreted as beingmediated by absorption of extravascularwater at the lung, reduced right and left heartfilling pressures, and increased left atrial com-

Table 3 Echocardiographic data in study and control population at baseline and duringfollow up (values are mean (SD))

Baseline Ultrafiltration Day 4 Day 30 Day 90

Study populaionLeft ventricular diameter (mm):

Diastolic 74 (5-9) 72 (5-7)* 72-4 (6.7)* 72-8 (6-7) 73-1 (6-7)Systolic 62-7 (5-9) 60-2 (7-3)* 60-7 (6)* 61-1 (6-1) 61-7 (5 8)

Fibre fractional shortening (%) 15-9 (5 3) 16 6 (8-9) 16 8 (6) 16-5 (583) 16-8 (5-3)Left ventricular:End diastolic volume (ml) 311 (61) 299 (54)* 280 (56)* 306 (46) 296 (66)Ejection fraction (%) 23-8 (8 7) 24 (6-7) 24 (6) 25-6 (6-1) 24-2 (5 3)

Cardiac index (I/min/m2) 2-8 (0-5) 2-4 (0-7)* 2-8 (0 5) 2-8 (0 5) 2-8 (0 6)Leftatrial diameter (mm) 47-7 (4-2) 45-6 (4 9)* 45-3 (4)* 45-6 (4) 46 (5)Right atrial area (cm2) 17-1 (4 9) 14-8 (2.6)* 14 6 (2.8)* 15 (3) 16 2 (5-1)Right ventricular area (cm2) 18-7 (6 1) 16-8 (7) 16-2 (6)* 16-5 (8) 17-5 (7)

Control populationLeft ventricular diameter (mm):

Diastolic 73-5 (5 6) 73-6 (5-7) 73-8 (5 7) 73-6 (5-7)Systolic 61-9 (5-9) 62 (5 8) 62 (5 8) 61-8 (5-9)

Fibre fractional shortening (%) 15-7 (5 3) 15 7 (5 4) 15-9 (5 4) 16 (5 6)Left ventricular:End diastolic volume (ml) 300 (68) 305 (70) 295 (73) 300 (75)Ejection fraction (%) 24-2 (9) 24-3 (9) 24-4 (10) 25 (10)

Cardiac index (min/m2) 2-7 (0 5) 2-8 (0 6) 2-8 (0 6) 2-7 (0 6)Left atrial diameter (mm) 48 (4 5) 48 (4-5) 48-2 (4-7) 48-3 (4 7)Right atrial area (cm2) 18 (4 9) 18-1 (5) 18 1 (5) 18-4 (6)Right ventricular area (cm2) 18-8 (6-2) 18 8 (6-3) 18 9 (7) 18-7 (6 5)

*p < 0-01 Compared with corresponding control group value.

138

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from

Page 5: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heartfailure: pathophysiological correlates

Table 4 Doppler data in study and control populations at baseline and during follow up. Values are mean (SD).

Baseline Ultrafiltration Day 4 Day 30 Day 90

Study populationMitral valve:PFVE (m/s) 0-78 (0 34) 0-6 (0 34)* 0-59 (0-31)* 0 59 (0-31)* 0 74 (0.38)PFVA (m/s) 0-56 (0.3) 0-68 (0 32)* 0 7 (0-29)* 0-7 (0-3)* 0-65 (0 26)*PFVEIPFVA 2 (2) 1 1 (1-1)* 1-5 (0 54)* 1-5 (1-6)* 1-4 (0 8)*DT (ms) 153 (32) 191 (41)* 186 (40)* 182 (36)* 179 (37)*

Tricuspid valve:PFVE (m/s) 0-42 (0 11) 0-34 (0-09)* 0-37 (0-04)* 0-37 (0.04)* 0-36 (0-06)*PFVA (m/s) 0 40 (0 11) 0-51 (0-17)* 0-52 0-15)* 0 53 (0-14)* 0-48 (0-13)*PFVE/PFVA 1-3 (1-3) 0-69 (0-18)* 0-8 (0-13)* 0-81 (0-15)* 093 (0.34)*DT (ms) 209 (57) 233 (56)* 238 (53)* 239 (50)* 239 (40)*

ControlpopulationMitral valve:PFVE (m/s) 0-8 (0 36) 0 79 (0 35) 0-8 (0 35) 0-8 (0 36)PFVA (m/s) 0-51 (0 3) 0 50 0 39) 0 49 (0 32) 0-49 (0-31)PFVE/PFVA 1.9 (1.8) 1-9 (1 9) 2 (1 9) 2 (2)DT (ms) 158 (30) 153 (33) 150 (33) 153 (35)

Tricuspid valve:PFVE (m/s) 0-43 (0-11) 0 43 (0-13) 0 44 (0-15) 0 44 (0-16)PFVA (m/s) 0-36 0 11) 0-37 (0-13) 0-36 (0-15) 0-36 (0 11)PFVE/PFVA 1-4 (1-3) 1-4 (1-4) 1-4 (1-3) 1-42 (1-3)DT (ms) 200 (50) 205 (53) 195 (50) 198 (59)

PFVE = peak flow velocity in early diastole; PFVA = peak flow velocity in late diastole; DT = deceleration time.*p < 0-01 Compared with corresponding control group value.

pliance. These mechanisms may apply topatients in our study in whom signs of exces-sive interstitial lung water regressed in parallelwith reduced filling pressures of the two sidesof the heart. A decrease of circulatory volumemay not be the only reason for this: reductionin pressure outside the heart because ofabsorption of lung water may play a part."I Inthese patients lung stiffness was probablyincreased'9 and a higher intrapleural pressurewas required for distention of the lungs.20That extramyocardial forces, and not solelythe intravascular volume, interfered with ven-

Mitral and tricuspidflowpatterms at various stages ofstudy. Bars are thecorresponding means (SD)ofPFVEIPFVA of wholepopulation. Day 0corresponds to ultrafiltration(*p < 0 001 comparedwith control value.)

tricular filling is also supported by two facts:the pattern of ventricular filling varied in asimilar manner in the two sides of the heartand changes persisted for much longer thanthe time required for the circulatory volumeto be restored after-ultrafiltration.2'

Withdrawal of plasma water caused, bothshort term and long term, a redistribution offilling of either ventricle to late diastole. Infact, the ratio of early to late ventricular fillingwas reduced in both sides of the heart andthere was an increase in the deceleration timeof mitral and tricuspid flow. In normal hearts

1... * , i

.~I

25-

- 2 0-0>

EL 15-

-6-10-

0.5-Fl 71

*

[

*

-1 0

* *

4

Day

30

.I . I I I

LX 1-5-0-wU-

-0 i.o0

VQ.50.

C.,

.. 4.

t4|i81-~~A

139

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from

Page 6: Sustainedcardiac · hydrostatic forces (left atrial pressure) that facilitate anexcessive filtration offluid. These categories of drugs, however, may cause humoral effects (stimulation

Pepi, Marenzi, Agoswni, Doria, Barbier, Muratori, Celeste, Guazzi

reduction of left atrial pressure causes a pro-

portional decrease in peak early and latemitral flow velocity22; in dilated hearts withraised left ventricular diastolic pressure, how-ever, reduction of left atrial pressure lowersonly the peak of early mitral flow velocity.2324The increased left atrial pressure in patientswith heart failure masks a relaxation abnor-mality of the left ventricle through normalisa-tion of the early diastolic transmitral pressuregradient.25 This normalised pattern resemblesa restrictive left ventricular filling pattern withpremature cessation of mitral flow in earlydiastole because of the presence of a dip-plateau contour of the left ventricular pres-

sure. Lavine et al found that redistribution offilling to early diastole in an acutely dilatedleft ventricle with raised diastolic pressure isthe consequence of pericardial restraint.26 Inpatients with idiopathic or ischaemic dilatedcardiomyopathy right and left ventricularinteraction and pericardial restraint have an

important part in the ventricular filling pat-tern.27-29 Changes in ventricular filling afterultrafiltration may well be explained bychanges in the diastolic pressure of both ven-

tricles as well as in extramyocardial forces. Infact, radiological changes reflecting the lungwater were strongly related to changes inDoppler data.Our findings support the suggestion that in

patients with idiopathic or ischaemic dilatedcardiomyopathy the functional class corre-

lates better with the diastolic than with thesystolic function.30 In our patients functionalperformance varied in parallel with variationsin the Doppler pattern of mitral and tricuspidflow. What remains to be defined is whetherthe degree of physical performance dependedon the diastolic function or both were a con-

sequence of the lung water reabsorption.In conclusion, we found that moderate

congestive heart failure may be associatedwith fluid accumulation in the interstitialspace of the lung, which although clinicallysilent, may interfere with the diastolic proper-

ties of the heart and the patient's functionalperformance.

1 Weaver LJ, Carrico CJ. Congestive heart failure andedema. In: Staub NC, Taylor AE, eds. Edema. NewYork: Raven, 1984:543-62.

2 Biddle TI, Yu PN. Effect of furosemide on hemodynam-ics and lung water in acute pulmonary edema secondaryto myocardial infarction. Am _Cardiol 1979;43:86-90.

3 Stevenson LW, Fonarow G. Vasodilators. A re-evaluationof their role in heart failure. Drugs 1992;43:15-36.

4 Bayliss J, Noreli M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroen-docrine effects of introducing diuretics. Br Heart1987;57: 17-22.

5 Forfar JC. Neuroendocrine activation in congestive heartfailure. Am JCardiol 1991;67:3-5C.

6 Broquist M, Dahlstrom U, Karlberg BE, Karlsson E,

Marklund T. Neuroendocrine response in acute heartfailure and the influence of treatment. Eur Heart J1989;1O: 1075-83.

7 Franciosa JA, Silverstein SR, Wilen M. Hemodynamiceffects of nitroprusside and furosemide in left ventricu-lar failure. Clin Pharmacol Ther 1982;32:62-9.

8 Nelson G, Silke B, Forsyth DR, Verma SP, Hussain M,Taylor SH. Hemodynamic comparison of primaryvenous or arteriolar dilation and the subsequent effect offurosemide in left ventricular failure after acute myocar-dial infarction. AmJ Cardiol 1983;52:1036-40.

9 Silverstein M, Ford C, Lysaght M, Henderson L.Treatment of severe fluid overload by ultrafiltration.NEnglJMed 1974;15:747-51.

10 Page E, Machecourt J, Wolf J, Boulard P, Denis B.Traitment des insuffisances cardiaques avec oedemesrefractaires par ultrafiltration extracorporelle. Arch MalCoeur 1984:9:1040-5.

11 Rimondini A, Cipolla C, Della Bella P, Grazi S, Sisillo E,Susini G, et al. Hemofiltration as short-term treatmentfor refractory congestive heart failure. Am J Med1987;83:43-8.

12 L'Abbate A, Emdin M, Piacenti M, Panichi V, Biagini A,Clerico A, et al. Ultrafiltration: a rational treatment forheart failure. Cardiology 1989;76:384-90.

13 Cipolla C, Grazi S, Rimondini A, Susini G, Guazzi M,Della Bella P, et al. Changes in circulating norepineph-rine with hemofiltration in advanced congestive heartfailure. Am J Cardiol 1990;66:987-94.

14 Susini G, Zucchetti M, Bortone F, Salvi L, Cipolla C,Rimondini A, et al. Isolated ultrafiltration in cardiogenicpuhmonary edema. Crit Care Med 1990;18:14-7.

15 Miyatake K, Izumi S, Okamoto M, Kinoshita N,Asonuma H, Nakagawa H, et al. Semiquantitative grad-ing of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. JAm CoilCardiol 1986;7:82-8.

16 Weber KY, Janicki JS, McElroy PA. Determination ofaerobic capacity and the severity of chronic cardiac andcirculatory failure. Circulation 1987;76 (suppl VI): VI40-5.

17 Ilhen H, Pamlie J, Dale J, Forfang K, Nitier-Hange S,Otterstad J, et al. Determination of cardiac output byDoppler echocardiography. Br HeartJ 1984;51:54-60.

18 Pistolesi M, Giuntini C. Assessment of extravascular lungwater. Radiol Clin North Am 1978;16:551-74.

19 Hauge A, Bo G, Waaler BA. Interrelations between pul-monary liquid volumes and lung compliance. J7 ApplPhysiol 1975;38:608-14.

20 Agostoni PG, Butler J. Cardiopulmonary interactions inexercise. In: BJ Whipp, K Wasserman, eds. Exercise.Pulmonary physiology and pathophysiology. New York:New York, 1991; 221-52.

21 Basile C, Coates E, Ulan RA. Plasma volume changesinduced by hypertonic hemofiltration and standardhemodyalisis. Am J Nephrol 1987;7:264-9.

22 Nishimura R, Abel M, Hatie L, Holmes D, Housmans P,Ritman E, et al. Significance of Doppler indices of dias-tolic filling of the left ventricle: comparison with invasivehemodynamics in a canine model. Am Heart J71989;118: 1248-58.

23 Choong C, Herrmann H, Weyman A, Fifer M. Preloaddependence of Doppler-derived indexes of left ventricu-lar diastolic function in humans. J Am Coil Cardiol1987;10:800-8.

24 David D, Lang R, Neumann A, Sareli P, Marcus R, et al.Comparison of Doppler indexes of left ventricular dias-tolic function with simultaneous high fidelity left atrialand ventricular pressures in idiopathic dilated cardiomy-opathy. Am Y Cardiol 1989;64:1173-9.

25 Appleton C, Hatle L, Popp RL. Relation of transmitralflow velocity patterns to left ventricular diastolic func-tion: new insights from a combined hemodynamic andDoppler echocardiographic study. J Am Coil Cardiol1988;12:426-40.

26 Lavine S, Campbell C, Kloner R, Gunther S. Diastolicfilling in acute ventricular dysfunction: role of the peri-cardium. JAm Coil Cardiol 1988;12:1326-33.

27 Shirato K, Shabetai R, Bhargava V, Franklin D, Ross J.Alteration of the left ventricular diastolic pressure-seg-ment length relation produced by the pericardium.Effects of cardiac distension and afterload reduction inconscious dogs. Circulation 1978;57:1191-8.

28 Hoit B, Dalton N, Bhargava V, Shabetai R. Pericardialinfluences on right and left ventricular filling dynamics.Circ Res 1991;68:197-208.

29 Bove A, Santamore W. Ventricular interdependence. ProgCardiovasc Dis 1981;23:365-87.

30 Vanovershelde J, Raphael D, Robert A, Cosyns J. Leftventricular filling in dilated cardiomyopathy: relation tofunctional class and hemodynamics. Y Am Coi Cardiol1990;15:1288-95.

140

on February 23, 2020 by guest. P

rotected by copyright.http://heart.bm

j.com/

Br H

eart J: first published as 10.1136/hrt.70.2.135 on 1 August 1993. D

ownloaded from